2014 CRO Leadership Awards Winner
Categories Won:
-
Quality
-
Regulatory
-
Productivity
Drug Life Cycle Stages:
Research & Development: Clinical (Phase 1, Phase 2, and Phase 3)
Main Service Areas:
Bioanalytical, Clinical
Services & Capabilities:
Bioanalytical/Immunoassay — biomarker development, method transfer and validation, pharmacokinetic
analysis and reporting; Clinical Research — clinical pharmacology, bridging studies, dyna-bridging studies, drug-drug interactions, pharmacodynamic modeling; Clinical Development — protocol development, feasibility, project management, medical monitoring, clinical monitoring, site management, data management, rater training, biostatistics and data analysis, medical writing, regulatory affairs,
quality assurance, drug and supply depots, drug safety
Therapeutic Areas:
CNS, cardiovascular, oncolog
Neal R. Cutler, M.D.CEO“At WCT , drug development is personal. We believe a strategic balance of science, medicine, and operations provides the foundation for successful execution of clinical trials. Quality is inherent in everything we do; it’s very gratifying to know our clients feel exactly the same way.” |
|